InspireMD Inc Cash Flow Conversion Efficiency
InspireMD Inc cash flow conversion efficiency. Based on the latest financial reports, InspireMD Inc (NSPR) has a cash flow conversion efficiency ratio of -0.265x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-10.89 Million) by net assets ($41.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of InspireMD Inc (2008–2025)
Cash flow conversion efficiency of InspireMD Inc from 2008 to 2025. This chart illustrates how InspireMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View InspireMD Inc share price for real-time trading data and today's change.
InspireMD Inc Cash Flow Conversion Ratio Explained
InspireMD Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
InspireMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InspireMD Inc ranked by their cash flow conversion efficiency. Also see NSPR company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Playside Studios Ltd
AU:PLY
|
0.100x |
|
Next Bt Co. Ltd
KQ:065170
|
-0.070x |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
-0.169x |
|
Hipay Group SA
PA:ALHYP
|
0.086x |
|
Atlantaa Limited
NSE:ATLANTAA
|
-0.073x |
|
Edesa Biotech Inc
NASDAQ:EDSA
|
-0.346x |
|
Commerce Resources Corp.
V:CCE
|
-0.001x |
|
Big Camera Corporation Public Company Limited
BK:BIG
|
-0.016x |
Annual Cash Flow Conversion Efficiency for InspireMD Inc (2008–2025)
The table below shows the annual cash flow conversion efficiency of InspireMD Inc from 2008 to 2025. Review NSPR cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $55.20 Million | $-35.10 Million | -0.636x | -4.94% |
| 2024-12-31 | $36.09 Million | $-21.87 Million | -0.606x | -46.17% |
| 2023-12-31 | $39.50 Million | $-16.38 Million | -0.415x | +53.61% |
| 2022-12-31 | $17.39 Million | $-15.54 Million | -0.894x | -126.82% |
| 2021-12-31 | $33.53 Million | $-13.21 Million | -0.394x | +47.23% |
| 2020-12-31 | $12.16 Million | $-9.08 Million | -0.747x | +59.03% |
| 2019-12-31 | $5.38 Million | $-9.81 Million | -1.822x | -109.96% |
| 2018-12-31 | $8.76 Million | $-7.61 Million | -0.868x | +70.89% |
| 2017-12-31 | $2.73 Million | $-8.13 Million | -2.982x | -60.92% |
| 2016-12-31 | $4.04 Million | $-7.50 Million | -1.853x | -147.07% |
| 2015-12-31 | $-2.95 Million | $-11.60 Million | 3.936x | -43.34% |
| 2014-12-31 | $-2.79 Million | $-19.36 Million | 6.947x | +465.44% |
| 2013-12-31 | $5.42 Million | $-10.30 Million | -1.901x | -19.34% |
| 2012-12-31 | $5.39 Million | $-8.58 Million | -1.593x | 0.00% |
| 2011-12-31 | $5.39 Million | $-8.58 Million | -1.593x | -119.31% |
| 2010-12-31 | $-2.30K | $-18.98K | 8.249x | 0.00% |
| 2009-12-31 | $-2.30K | $-18.98K | 8.249x | +1774.80% |
| 2008-12-31 | $1.68K | $-825.00 | -0.493x | -- |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more